189 filings
Page 8 of 10
20-F
badwjm8vb2z251c
17 Mar 17
Annual report (foreign)
12:00am
6-K
p5x etq7c5hf1c
17 Mar 17
AC IMMUNE reports Full year 2016 financial results
12:00am
S-8
y0b0socard628zk4am
8 Mar 17
Registration of securities for employees
12:00am
6-K
k6cl1yfnn
16 Dec 16
Current report (foreign)
12:00am
6-K
wqbx x8u8w7qw
23 Nov 16
Ac Immune Appoints Experienced Life Science
12:00am
6-K
wdg ivz9iflr
15 Nov 16
Current report (foreign)
12:00am
6-K
gdzvsnfrdgy1ic
14 Nov 16
Unaudited interim condensed financial statements
12:00am
6-K
sy497 5c31l06
13 Oct 16
Invitation to the Ordinary Shareholders' Meeting
12:00am
S-8
ibavpkmphsef2z5
29 Sep 16
Registration of securities for employees
12:00am
424B4
xxfl0 v3g
23 Sep 16
Prospectus supplement with pricing info
12:00am
8-A12B
aee3am06 fwmlrgv
23 Sep 16
Registration of securities on exchange
12:00am
CT ORDER
oiwhib
23 Sep 16
Confidential treatment order
12:00am
EFFECT
sit7cige p6ep92
22 Sep 16
Notice of effectiveness
12:00am
F-1/A
s2ofp8991yzoa7wm
22 Sep 16
Registration statement (foreign) (amended)
12:00am
F-1/A
71v 2ffwkcy
21 Sep 16
Registration statement (foreign) (amended)
12:00am
FWP
vnokgm3
21 Sep 16
Free writing prospectus
12:00am
CORRESP
zdsdmn3l
20 Sep 16
Correspondence with SEC
12:00am
CORRESP
yiapif qusgvbapg9
20 Sep 16
Correspondence with SEC
12:00am
CORRESP
q4r g002rd6wgh0ukp
20 Sep 16
Correspondence with SEC
12:00am
CORRESP
hinjulh6w9nfi2sp5p9
16 Sep 16
Correspondence with SEC
12:00am